Therapeutic opportunities through modulation of the endocannabinoid system

Neuropharmacology. 2005 Jun;48(8):1068-71. doi: 10.1016/j.neuropharm.2005.03.012.
No abstract available

Publication types

  • Congress

MeSH terms

  • Animals
  • Cannabinoid Receptor Agonists*
  • Cannabinoid Receptor Antagonists*
  • Cannabinoid Receptor Modulators / metabolism*
  • Cannabinoid Receptor Modulators / physiology
  • Cannabinoids / adverse effects
  • Cannabinoids / pharmacology
  • Cannabinoids / therapeutic use*
  • Drug Discovery
  • Endocannabinoids*
  • Humans
  • Obesity / drug therapy
  • Oleic Acids / pharmacology
  • Substance-Related Disorders / drug therapy

Substances

  • Cannabinoid Receptor Agonists
  • Cannabinoid Receptor Antagonists
  • Cannabinoid Receptor Modulators
  • Cannabinoids
  • Endocannabinoids
  • Oleic Acids
  • Oleylethanolamide